AKT1 and neoplasm: We further demonstrate that elevated expression of ZFX/UGCG alters ganglioside levels and activates epidermal growth factor receptor (EGFR)-mediated PI3K/AKT/mTOR/MAPK signaling, leading to tumor progression.